Latest News and Press Releases

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION30 September 2024, 23:55 CEST Sequana Medical announces H1 2024 results and provides business update alfapump® - US FDA approval anticipated...

Transparantiekennisgeving van Aandeelhouders Gent, België – 9 augustus 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een pionier in de behandeling van...

Transparency Notification from Shareholders Ghent, Belgium – 9 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...

PRESS RELEASEREGULATED INFORMATION 5 August 2024, 06 pm CEST Transparency Notification from Shareholders Ghent, Belgium – 5 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...

Transparency Notification from Shareholders PRESS RELEASEREGULATED INFORMATION 1 August 2024, 06:30 pm CEST Ghent, Belgium – 1 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...

Transparency Notifications from Shareholders PRESS RELEASEREGULATED INFORMATION19 July 2024, 06:30 pm CEST Ghent, Belgium – 19 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...

PRESS RELEASEREGULATED INFORMATION10 July 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 10 July 2024 – Sequana Medical NV...

SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN Gent, België, 5 juli 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een...

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 5 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer...

Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024 “alfapump implantation significantly improved quality of life and showed similar safety...